Apotex

Olivieri Honoured with Prestigious Award

Rating: 
5
Dr. Nancy Olivieri
Dr. Nancy Olivieri

The CAUT Bulletin – March 2010

Nancy Olivieri has been honoured by the American Association for the Advancement of Science with its Scientific Freedom and Responsibility Award “for her indefatigable determination that patient safety and research integrity come before institutional and commercial interests.”

Olivieri, a professor of pediatrics, medicine and public health sciences at the University of Toronto, showed “courage in defending these principles in the face of severe consequences,” the award selection committee noted.

Toronto doctor recognized for her courage

Rating: 
5

Theresa Boyle Health Reporter – Wed Feb. 17, 2010

A Toronto doctor who defied a drug company by warning patients of potential dangers of a drug she was studying is being recognized for her courage.

Dr. Nancy Olivieri is the 2009 recipient of the “scientific freedom and responsibility award” from the American Association for the Advancement of Science, the same organization that publishes Science magazine.

Apotex Inc.: A Corporation Above the Courts?

Rating: 
0

CAUT – January 2009

The Canadian Association of University Teachers (CAUT) believes a new legal tactic adopted by Canadian pharmaceutical corporation Apotex Inc. against Canadian university teacher Dr. Nancy Olivieri is a blatant misuse of the Canadian legal system.

In a late December appeal to the Court of Appeal for Ontario, Apotex has requested to be relieved from complying with a settlement it entered into with Dr. Olivieri in 2004 to resolve defamation litigation.

New Chapter in Apotex Legal Battle

Rating: 
2

Legal Action Cited as a Threat to Freedom of Speech

By Elizabeth Church, education reporter
Globe & Mail: December 1st, 2008

The legal wrangling between Toronto physician and researcher Nancy Olivieri and Apotex Inc. is continuing after more than a decade, with a new lawsuit by the drug maker raising fresh charges it is trying to muzzle academic freedom.

Subscribe to Apotex